PULM
Pulmatrix Inc
Halal Rating :
Last Price
$6.17
Last updated:
Market Cap
-
7D Change
3.01%
1 Year Change
239.01%
Company Overview
Industries
Exchange
Next Earnings Date
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology. The company develops treatments for respiratory diseases and lung infections.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $366000.0 | $2.92m | - | $-101000.0 | 0.00% | 3.46% |
| June 30, 2024 | $1.55m | $7.32m | - | $-133000.0 | 0.00% | 1.82% |
| March 31, 2024 | $5.88m | $4.98m | - | $-160000.0 | 0.00% | 3.21% |
Company Impact
Help us evaluate Pulmatrix Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.